Immunological profile and dyslipidemia in Egyptian Systemic Lupus Erythematosus patients

Nisar, 2012, Prevalence of dyslipidemias in autoimmune rheumatic diseases, J Coll Phys Surg Pakistan, 22, 235 Spellman, 2003, Strategies for optimizing lipid treatment out comes, J Am Osteopath Assoc, 103, S12 van der Burg, 2015, Cardiovascular morbidity and mortality among working individuals withrheumaticdisease: results from a large prospective cohort study, J Clin Rheumatol, 21, 359, 10.1097/RHU.0000000000000294 Turesson, 2008, Cardiovascular comorbidity in rheumatic diseases, Vasc Health Risk Manag, 4, 605, 10.2147/VHRM.S2453 Rizk, 2012, The impact of obesity in systemic lupus erythematosus on disease parameters, quality of life, functional capacity and the risk of atherosclerosis, Int J Rheum Dis, 15, 261, 10.1111/j.1756-185X.2011.01698.x Sella, 2003, Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus, Ann Rheum Dis, 62, 1066, 10.1136/ard.62.11.1066 Kiani, 2011, Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus, Rheumatology (Oxford), 50, 2071, 10.1093/rheumatology/ker285 Mankad, 2015, Atherosclerotic vascular disease in the autoimmune rheumatologic patient, Curr Atheroscler Rep, 17, 497, 10.1007/s11883-015-0497-6 Fadda, 2015, Subclinical atherosclerosis in systemic lupus erythematosus patients and its relationship to disease activity and damage indices, Z Rheumatol, 74, 529, 10.1007/s00393-014-1473-1 Rahman, 2004, Autoantibodies, lupus and the science of sabotage, Rheumatology (Oxford), 43, 1326, 10.1093/rheumatology/keh354 Yang, 2015, Co-positivity for anti-dsDNA, -nucleosome and -histone antibodies in lupus nephritis is indicative of high serum levels and severe nephropathy, PLoS ONE, 10, e0140441, 10.1371/journal.pone.0140441 Gamal, 2013, Does anti-DNA positivity increase the incidence of secondary antiphospholipid syndrome in lupus patients?, Egypt Rheumatol, 35, 141, 10.1016/j.ejr.2013.02.001 Gilliam, 2012, Measurement of autoantibodies in pediatric-onset systemic lupus erythematosus and their relationship with disease-associated manifestations, Semin Arthritis Rheum, 41, 840, 10.1016/j.semarthrit.2011.09.009 Pradhan, 2002, Antibodies to Ro/SS-A and La/SS-B in systemic lupus erythematosus and other autoimmune disorders, J Assoc Physicians India, 50, 762 Petri, 2012, Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus, Arthritis Rheum, 64, 2677, 10.1002/art.34473 Bombardier, 1992, Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE, Arthritis Rheum, 35, 630, 10.1002/art.1780350606 Gladman, 1997, The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus, Arthritis Rheum, 40, 809, 10.1002/art.1780400506 Reiner, 2011, ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Eur Heart J, 32, 1769, 10.1093/eurheartj/ehr158 Hsieh, 2013, Autoantibody profiling in systemic lupus erythematosus, Curr Biomarker Find, 3, 55 Thompson, 1993, The clinical significance of autoantibody profiles in patients with systemic lupus erythematosus, Lupus, 2, 15, 10.1177/096120339300200104 Aranow, 2000, Epidemiology of cardiovascular disease in systemic lupus erythematosus, Lupus, 9, 166, 10.1191/096120300678828208 Tselios, 2016, Dyslipidemia in systemic lupus erythematosus: just another comorbidity?, Semin Arthritis Rheum, 45, 604, 10.1016/j.semarthrit.2015.10.010 Svenungsson, 2001, Risk factors for cardiovascular disease in systemic lupus erythematosus, Circulation, 104, 1887, 10.1161/hc4101.097518 Toms, 2011, Dyslipidemia in rheumatological autoimmune diseases, Open Cardiovasc Med J, 5, 64, 10.2174/1874192401105010064 Khairy, 2017, Atherosclerosis biomarkers in female systemic lupus erythematosus patients with and without cardiovascular diseases, Egypt Rheumatol, 39, 7, 10.1016/j.ejr.2016.03.003 Wasicek, 1982, Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La, J Clin Invest, 69, 835, 10.1172/JCI110523